I now have comprehensive material across all domains. Here is the complete answer:
Syncope
Definition
Syncope is an abrupt, transient, and complete loss of consciousness with inability to maintain postural tone, followed by spontaneous, complete recovery. The underlying mechanism is always transient cerebral hypoperfusion. Episodes that are incomplete (i.e., lightheadedness without loss of consciousness) are termed presyncope and carry similar clinical significance.
Syncope must be distinguished from cardiac arrest (loss of consciousness without spontaneous recovery) and from seizure, hypoglycemia, and psychogenic pseudo-syncope.
Epidemiology
- Lifetime prevalence: ~40%; recurrence rate: 14%
- Accounts for 1–3% of ED visits and 6% of hospital admissions
- Annual cost of syncope hospitalizations:
$1.7 billion ($26,000/hospitalization)
- Incidence increases with age; in the Framingham Study: 3.0% in men, 3.5% in women over 26 years
- Cause remains unknown in up to 50% of patients despite extensive evaluation
Pathophysiology
The common final pathway is a fall in cerebral perfusion below the threshold for consciousness. This can result from:
- Reduced cardiac output (arrhythmia, obstruction)
- Reduced systemic vascular resistance (vasodilation)
- Reduced venous return / preload (hypovolemia, venous pooling)
- Combinations of the above
Classification & Causes
1. Reflex (Neurally Mediated) Syncope — Most Common
Caused by inappropriate vasodilation, bradycardia, or both due to sudden failure of autonomic tone.
| Type | Mechanism / Trigger | Features |
|---|
| Vasovagal (neurocardiogenic) | Prolonged standing, emotional stress, pain, venipuncture, warm/crowded environment | Prodrome: nausea, pallor, diaphoresis, lightheadedness, warmth, blurred vision; more common in young people |
| Carotid sinus syndrome | Pressure on carotid sinus (shaving, tight collar, head turning) → sinus arrest/AV block (cardioinhibitory) and/or vasodilation (vasodepressor) | More common in men ≥50 years; positive carotid sinus massage: pause ≥3 s and/or SBP drop ≥50 mmHg |
| Situational | Micturition, defecation, coughing, swallowing, laughing, sneezing, post-exercise, postprandial | Closely linked to a specific provoking action |
Mechanism of vasovagal syncope: venous pooling in dependent areas → decreased venous return → reflex increase in myocardial contractility → activation of ventricular mechanoreceptors (normally fired only during stretch) → paradoxic decrease in sympathetic outflow (hypotension) + increased vagal tone (bradycardia → sometimes asystole on tilt-table).
2. Orthostatic Syncope
Defined as a fall in SBP ≥20 mmHg and/or DBP ≥10 mmHg within 3 minutes of standing.
| Subtype | Examples |
|---|
| Hypovolemia | Dehydration, hemorrhage, Addison disease |
| Drug-induced | Antihypertensives (β-blockers, CCBs, nitrates, ACEi/ARBs, diuretics), antidepressants (TCAs, MAOIs, SSRIs), antipsychotics, levodopa, opioids, alcohol |
| Autonomic dysfunction | Diabetes, Parkinson disease, multisystem atrophy, amyloidosis |
| Deconditioning / prolonged bed rest | |
3. Cardiac Syncope — Highest Mortality
Cardiac syncope from cardiovascular disorders is associated with ~50% mortality over 5 years and ~30% in the first year. Must be actively excluded.
Arrhythmic causes:
- Sinus node dysfunction (sinus bradycardia < 40 bpm, sinus pauses > 3 s)
- AV block (Mobitz II, complete heart block)
- Supraventricular tachycardias (SVT, AF/flutter with rapid ventricular response)
- Ventricular tachycardia / fibrillation
- Long QT syndrome (congenital or acquired), Brugada syndrome, CPVT
- Pacemaker dysfunction
Structural / obstructive causes:
- Aortic stenosis (syncope = severe obstruction, poor prognosis)
- Hypertrophic cardiomyopathy (exertional syncope = high SCD risk)
- Mitral stenosis
- Atrial myxoma
- Prosthetic valve dysfunction
- Pulmonary embolism / pulmonary hypertension
- Cardiac tamponade
- Acute MI / ischemia
4. Cerebrovascular
- Vertebrobasilar TIA / insufficiency — syncope nearly always preceded by vertigo, diplopia, dysarthria, ataxia
- Subclavian steal syndrome — upper extremity exertion shunts blood retrograde via vertebral artery
- Occlusive disease (Takayasu arteritis, aortic arch syndrome)
- Klippel-Feil deformity / cervical spondylosis (vertebral artery compression)
Syncope vs. Seizure — Key Differentiators
| Feature | Syncope | Seizure |
|---|
| Posture-related | Common | No |
| Skin color | Pallor | Cyanosis or normal |
| Diaphoresis | Common | Rare |
| Prodrome | Often prolonged (minutes) | Brief aura |
| Convulsions | Rare; minor irregular twitching | Common; rhythmic jerks |
| Tongue biting | No | Common |
| Urinary incontinence | Rare | Common |
| Postictal confusion | Rare | Common |
| Postictal headache | No | Common |
| ECG/EEG | Normal | Often abnormal |
Syncope has been misdiagnosed as seizure in 38% of patients who continued to have episodes despite anticonvulsant therapy — a critical clinical trap.
Clinical Approach
History
Key clinical context questions:
- Position at onset — lying/sitting/standing (orthostatic vs. cardiac)?
- Activity — exertional (cardiac outflow obstruction, arrhythmia, ARVC, CPVT) vs. at rest?
- Prodrome — nausea/diaphoresis (vasovagal) vs. palpitations (arrhythmia) vs. none (cardiac, elderly)?
- Duration — brief and sudden = cardiac; gradual onset with prodrome = vasovagal
- Recovery — postictal confusion? (seizure); rapid and complete = syncope
- Triggers — specific situational triggers, head turning (carotid sinus), venipuncture, crowds
- Medications — QT-prolonging drugs, antihypertensives, antiparkinsonian agents
- Family history — sudden cardiac death (long QT, HCM, Brugada, ARVC)
Physical Examination
- Orthostatic BP (only useful if symptoms reproduced on standing)
- Blood pressure in both arms (subclavian steal, Takayasu)
- Heart rate during arrhythmia: >140 bpm = likely not sinus; <40 bpm = likely complete AV block
- Cardiac auscultation — murmurs (aortic stenosis: systolic ejection murmur; HCM: dynamic murmur)
- Signs of heart failure; new neurological deficit (not syncope — consider stroke/SAH)
- Carotid sinus massage (older patients, not routine in ED)
Investigations
ECG (12-lead) — Recommended in nearly all cases
ECG findings diagnostic of arrhythmic syncope:
- Sinus bradycardia < 40 bpm or pause > 3 s
- Mobitz II second-degree AV block
- Complete (third-degree) heart block
- Sustained SVT or VT
ECG findings raising concern for underlying cause:
- Prolonged QTc → long QT syndrome
- Short PR + delta wave → WPW (pre-excitation)
- RBBB + ST elevation V1–V3 → Brugada syndrome
- RV strain pattern → PE
- New LBBB → rule out STEMI
- Epsilon waves / RBBB + T-wave inversions V1–V3 → ARVC
Additional Testing
| Test | When |
|---|
| Holter monitor (24–48 h) | Suspected arrhythmia, frequent episodes |
| Event recorder (weeks) | Infrequent episodes |
| Implantable loop recorder (ILR) | Very infrequent episodes (weeks–months); diagnostic in ~2/3 of unexplained syncope |
| Echocardiogram | Suspected structural heart disease |
| Cardiac MRI | ARVC, HCM, inconclusive echo |
| Exercise stress test | Exertional syncope |
| Tilt-table test | Suspected neurocardiogenic or orthostatic syncope |
| Electrophysiology study (EPS) | HV interval ≥70 ms or infranodal block → pacing indication |
| Troponin | Only if ACS is suspected |
| BNP/NT-proBNP | Prognostic utility for 30-day adverse cardiac events |
| CT head | Only if head trauma after syncope, or new neurological deficit |
Routine labs (CBC, electrolytes, glucose) are not supported by evidence for standard syncope evaluation.
Prognosis
| Cause | Mortality |
|---|
| Cardiac syncope | ~50% at 5 years; ~30% in first year; all-cause mortality doubled vs. general population |
| Non-cardiac (reflex/orthostatic) | ~30% at 5 years; <10% in first year; more benign course |
| Unexplained syncope | 6–10% at 3 years; 24% at 5 years |
| Vasovagal / reflex | Benign; recurrence affects quality of life |
Syncope is an ominous sign in HCM (high SCD risk) and in aortic stenosis (severe obstruction, < 2–3 year survival without intervention).
Management
Reflex (Vasovagal) Syncope
- Non-pharmacologic first: education, avoid triggers, physical counterpressure maneuvers (leg crossing, arm tensing), liberal salt and fluid intake, compression stockings, tilt training
- Midodrine (α-agonist) — FDA-approved for orthostatic hypotension; reduces vasovagal recurrence
- SSRIs — randomized controlled trial evidence for prevention of recurrent neurocardiogenic syncope
- Fludrocortisone — volume expansion; evidence mixed
- Ivabradine — useful in POTS and neurocardiogenic syncope refractory to β-blockers
- Pyridostigmine — acetylcholinesterase inhibitor; prevents orthostatic BP falls without worsening supine hypertension
- Cardiac pacing — only in cardioinhibitory carotid sinus syndrome with documented pause; not routinely for vasovagal
Orthostatic Syncope
- Treat underlying cause; review/stop offending medications
- Volume expansion (fluids, salt, fludrocortisone)
- Midodrine, droxidopa (approved for neurogenic orthostatic hypotension)
- Head-of-bed elevation (reduces nocturnal natriuresis)
Cardiac Syncope
- Arrhythmic: permanent pacemaker (bradycardia, heart block); ICD (VT/VF, Brugada, long QT, HCM); catheter ablation (SVT, VT); antiarrhythmic drugs
- Structural: treat underlying disease (valve surgery/TAVR for AS; septal reduction for HCM; anticoagulation for PE)
- Bifascicular block with syncope + HV ≥70 ms on EPS: permanent pacing (Class I indication)
- Alternating BBB: pacemaker regardless of symptoms (Class I)
Sources: Fuster and Hurst's The Heart, 15th ed.; Bradley and Daroff's Neurology in Clinical Practice; Rosen's Emergency Medicine; Tintinalli's Emergency Medicine